Temozolamide-Based Chemo-Radiotherapy for High-Risk Low Grade Gliomas Reply

被引：0
|
作者：
Fisher, Barbara J. [1 ]
机构：
[1] Western Univ, Radiat Oncol, London, ON, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 04期
关键词：
D O I：
10.1016/j.ijrobp.2020.05.057
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1118 / 1118
页数：1
相关论文
共 50 条
  • [31] Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma
    Yong-Pyo Lee
    Hyun Ae Jung
    Min-Sang Lee
    Jung Won Choi
    Doo-Sik Kong
    Ho Jun Seol
    Do-Hyun Nam
    Jung-Il Lee
    Se-Hoon Lee
    Journal of Neuro-Oncology, 2022, 156 : 541 - 549
  • [32] Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
    Andruska, Neal
    Waters, Michael R.
    Fischer-Valuck, Benjamin W.
    Smith, Zachary L.
    Kim, Eric H.
    Reimers, Melissa
    Brenneman, Randall
    Gay, Hiram A.
    Patel, Sagar A.
    Michalski, Jeff M.
    Delacroix, Scott E.
    Efstathiou, Jason A.
    Baumann, Brian C.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (06) : 653 - +
  • [33] Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma
    Lee, Yong-Pyo
    Jung, Hyun Ae
    Lee, Min-Sang
    Choi, Jung Won
    Kong, Doo-Sik
    Seol, Ho Jun
    Nam, Do-Hyun
    Lee, Jung-Il
    Lee, Se-Hoon
    JOURNAL OF NEURO-ONCOLOGY, 2022, 156 (03) : 541 - 549
  • [34] Novel Cuproptosis-Related Gene Signature for Precise Identification of High-Risk Populations in Low-Grade Gliomas
    Chen, Ping
    Han, Hailing
    Wang, Xuejie
    Wang, Bing
    Wang, Zhanfeng
    MEDIATORS OF INFLAMMATION, 2023, 2023
  • [35] LONG-TERM FOLLOW UP OF HIGH-RISK LOW-GRADE GLIOMA PATIENTS TREATED WITH RADIOTHERAPY (RT) OR RT AND ADJUVANT TEMOZOLAMIDE OR PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) CHEMOTHERAPY AT A SINGLE INSTITUTION
    Kreofsky, Cole
    Youland, Ryan
    Buckner, Jan
    Uhm, Joon
    Lachance, Daniel
    Laack, Nadia
    NEURO-ONCOLOGY, 2016, 18 : 175 - 175
  • [36] Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV
    McDuff, Susan G. R.
    Dietrich, Jorg
    Atkins, Katelyn M.
    Oh, Kevin S.
    Loeffler, Jay S.
    Shih, Helen A.
    CANCER MEDICINE, 2020, 9 (01): : 3 - 11
  • [37] Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
    Andruska, N.
    Fischer-Valuck, B. W.
    Efstathiou, J. A.
    Smith, Z.
    Kim, E.
    Brenneman, R. J.
    Reimers, M.
    Gay, H. A.
    Patel, S. A.
    Michalski, J. M.
    Delacroix, S.
    Baumann, B. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E203 - E203
  • [38] Patients with low-grade gliomas respond well to proton-based radiotherapy
    Nature Reviews Neurology, 2015, 11 (2) : 68 - 68
  • [39] The efficacy of daily low-dose cisplatin based concurrent chemo-radiotherapy (CCRT) for the treatment of cervical cance
    Sugimori, Y.
    Hiranuma, K.
    Saito, M.
    Kasahara, M.
    Miwa, A.
    Yamaguchi, M.
    Shimanuki, H.
    Kusunoki, S.
    Matsuoka, S.
    Ogishima, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 472 - 472
  • [40] On high-risk, low-grade glioma: What distinguishes high from low?
    Geurts, Marjolein
    van den Bent, Martin J.
    CANCER, 2019, 125 (02) : 174 - 176
12345